Invited Commentary

Affiliations

Comment

Timothy L Fitzgerald. J Am Coll Surg. 2022.

. 2022 Jun 1;234(6):1031-1032.

doi: 10.1097/XCS.0000000000000200. Epub 2022 May 11.

No abstract available

Comment on

Number of Worrisome Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasm.
Zelga P, Hernandez-Barco YG, Qadan M, Ferrone CR, Kambadakone A, Horick N, Jah A, Warshaw AL, Lillemoe KD, Balakrishnan A, Fernández-Del Castillo C. Zelga P, et al. J Am Coll Surg. 2022 Jun 1;234(6):1021-1030. doi: 10.1097/XCS.0000000000000176. Epub 2022 Mar 22. J Am Coll Surg. 2022. PMID: 35703792

1. Zelga P, Hernandez-Barco YG, Qadan M, et al. Number of worrisome features and risk of malignancy in intraductal papillary mucinous neoplasm. J Am Coll Surg 2022;234:1021–1030.
1. Fitzgerald TL, Dennis SO, Kachare SD, et al. Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease? Surgery 2015;158:466–471.
1. Tanaka M, Fernández-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017;17:738–753.
1. Mohamed A, Nicolais L, Fitzgerald TL. Revisiting the pancreatic fistula risk score: clinical nomogram accurately assesses risk. Am Surg 2021:31348211047471.
1. Nikas IP, Mountzios G, Sydney GI, et al. Evaluating pancreatic and biliary neoplasms with small biopsy-based next generation sequencing (NGS): doing more with less. Cancers (Basel) 2022;14:397.